IHS Chemical Week

Archives :: Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Displaying 41 - 60 of 1259 stories.
February 16, 2015
Bayer is planning to reorganize its life science businesses, which include its health-care and crop science businesses, in anticipation of the separation of Bayer MaterialScience...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Bayer-to-reorganize-life-sciences-businesses-after-BMS-separation_67783.html
February 15, 2015
Fast-growing pharma group Cipla (Mumbai) has announced that it has agreed with existing partner Biopharm SPA to form a joint venture in Algeria. The jv will produce and market...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Cipla-to-form-jv-in-Algeria-acquires-majority-in-Jay-Precision-Pharma_67797.html
February 12, 2015
Albany Molecular (AMRI) today announced several key leadership changes. Steven Hagen, senior v.p./manufacturing and pharmaceuticals, has been given oversight of the company’s...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/AMRI-shuffles-leadership-roles_67772.html
February 12, 2015
SAFC Commercial, the custom-manufacturing and services business unit of Sigma-Aldrich (St. Louis), reports a 9.0% increase in sales in the fourth quarter of 2014 compared with the...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/SAFC-reports-rise-in-fourth-quarter-sales_67752.html
February 12, 2015
Albany Molecular (AMRI) has announced plans to close its facility at Holywell, Wales, UK, the company says. The plant makes active pharmaceutical ingredients (APIs) and is involved in...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/AMRI-plans-to-close-UK-plant_67767.html
February 10, 2015
Dishman Group (Ahmedabad, India), a leading outsourcing partner for the global pharmaceutical industry, announced today FDA has successfully completed inspecting its Veenendaal...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/FDA-approves-Dishman-site-in-the-Netherlands_67652.html
February 10, 2015
Informex 2015: CMOs benefit from changes at big pharma Contract manufacturing organizations (CMOs), including many fine chemical makers, are among the big beneficiaries from changes at...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-10-February-2015_67677.html
February 6, 2015
Cambrex (East Rutherford, NJ) today announced that it has initiated the second significant expansion of its Charles City, IA, facility in less than three years. The previous expansion...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Cambrex-to-expand-API-capacity-in-Iowa_67607.html
February 6, 2015
The active pharmaceutical ingredient (API) business of Teva Pharmaceutical Industries (PetaŠł• Tiqwa, Israel) reports a 1.7% rise in sales in the fourth quarter of 2014 compared with...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Tevas-API-business-reports-a-small-increase-in-sales_67603.html
February 6, 2015
Cambrex (East Rutherford, NJ) says its net profits for the fourth quarter of 2014 more than tripled compared with the fourth quarter of 2013, to $27.8 million. Net sales for the fourth...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Cambrex-reports-huge-rise-in-profits_67609.html
February 5, 2015
Contract manufacturing organizations (CMOs), including many fine chemical makers, are among the big beneficiaries from changes at big pharmaceutical companies, say attendees at...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Informex-2015-CMOs-benefit-from-changes-at-big-pharma_67545.html
February 5, 2015
Pfizer and Hospira (Lake Forest, IL) today announced that they have entered into a definitive merger agreement under which Pfizer will acquire Hospira, the world’s leading...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pfizer-to-acquire-Hospira-for-$17-billion_67537.html
February 4, 2015
Regulatory issues, most prominently reform of the Toxic Substances Control Act (TSCA) and trade barriers, have been key topics of discussion at Informex 2015, held this week in New...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Informex-2015-Regulatory-hurdles-persist-as-industry-expects-growth_67510.html
February 3, 2015
Galmed and Perrigo sign API manufacturing deal Galmed Pharmaceuticals (Tel Aviv), a company focused on developing and commercializing a once-daily, oral medication to treat liver...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-3-February-2015_67443.html
February 2, 2015
Amyris (Emeryville, CA) says it plans to offer its synthetic biology discovery and production platform to pharmaceutical makers. Amyris says it will offer an integrated discovery and...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Amyris-to-launch-biopharma-platform_67410.html
February 1, 2015
The FTC on Friday cleared Sun Pharmaceutical’s $4 billion proposed acquisition of Ranbaxy Laboratories on condition that the companies divest Ranbaxy’s interests in generic...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/FTC-clears-Sun-Pharmas-acquisition-of-Ranbaxy-on-condition-that-they-divest-a-business_67385.html
January 29, 2015
Ash Stevens (Riverview, MI), a provider of global contract pharmaceutical drug substance development and active pharmaceutical ingredient (API) manufacturing services, says that FDA...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Ash-Stevens-to-manufacture-amotosalen-API-for-Cerus_67310.html
January 29, 2015
Galmed Pharmaceuticals (Tel Aviv), a company focused on developing and commercializing a once-daily, oral medication to treat liver diseases and cholesterol gallstones, says that it...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Galmed-and-Perrigo-sign-API-manufacturing-deal_67309.html
January 29, 2015
The European Commission said on Wednesday that it has cleared both GlaxoSmithKline's (GSK) proposed acquisition of Novartis's vaccines business and the proposed creation of...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/EU-conditionally-approves-GSK-Novartis-deals_67307.html
January 29, 2015
Umicore (Brussels) says that its precious metals chemistry business unit has appointed a subsidiary of Midas Pharma (Ingelheim, Germany) at Parsippany, NJ, as the exclusive sales agent...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Umicores-API-business-appoints-sales-partner-for-North-America_67298.html
Pages: « Previous  1 2 [3] 4 5 6 7 8 9 10 11 12 Next »










 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa